Lian Kang

495 citations
14 papers · 352 indexed · h-index 9
Topics
Effects and risks of endocrine disrupting chemicals (7 papers)Pluripotent Stem Cells Research (3 papers)Testicular diseases and treatments (2 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Lian Kang

13 papers receiving 345 citations

Peers

Lian Kang
Comparison fields: 5 of 75
  • Health, Toxicology and Mutagenesis 154
  • Molecular Biology 151
  • Cancer Research 84
  • Pulmonary and Respiratory Medicine 83
  • Pollution 29
Replace Lindong Han with:
Lindong Han China
Mingming Yu China
Erdem Durmaz Türkiye
Maggie M. Ramzy Egypt
Kazuhisa Shimodaira Japan
Xiaoqin Yin China
Hisayo Kubota Japan
Ryan J. Snyder United States
Yong‐Sheng Wang China
K Ko South Korea
Lian Kang relative to Lindong Han China Lindong Han's profile →
Citations per field
00.5×1.5×
Lindong Han · 1×
Citations per year

Countries citing papers authored by Lian Kang

Since Specialization
Citations

This map shows the geographic impact of Lian Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian Kang more than expected).

Fields of papers citing papers by Lian Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lian Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian Kang. The network helps show where Lian Kang may publish in the future.

Co-authorship network of co-authors of Lian Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Lian Kang. A scholar is included among the top collaborators of Lian Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian Kang. Lian Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 6
2 8
3 8
4 0
5 6
6 8
7 6
8 9
9 157
10 39
11 24
12 15
13 4
14 62

About Lian Kang

Lian Kang is a scholar working on Health, Toxicology and Mutagenesis, Developmental Neuroscience and Reproductive Medicine, having authored 14 papers that have together received 352 indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (7 papers), Pluripotent Stem Cells Research (3 papers) and Testicular diseases and treatments (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (154 citations), Cancer Research (84 citations) and Reproductive Medicine (27 citations). Lian Kang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yuexin Wei, Shengde Wu, Guanghui Wei, Chunlan Long, Yuhao Wu, Jiadong Chen, Tianxin Zhao, Lindong Han, Junke Wang and Lianju Shen. Their work appears in journals such as Journal of Hazardous Materials, Biochemical and Biophysical Research Communications and Environmental Pollution.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026